Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiraag Kulkarni

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Clinical and Translational Gastroenterology|March 23, 2026
Response to Cardinale et alSidhartha R Sinha, Chiraag Kulkarni
Digestive Diseases and Sciences|May 25, 2023
Severe Diarrhea and Weight Loss Due to Protein-Losing Enteropathy: Don't Pass Up the PAS StainAaron Yeoh, Chiraag Kulkarni, Emily Ryan, et al.
Pacing and Clinical Electrophysiology : PACE|January 29, 2015
Risk prediction for adverse events during initiation of sotalol and dofetilide for the treatment of atrial fibrillationKartik Agusala, Adam Oesterle, Chiraag Kulkarni, et al.
Pacing and Clinical Electrophysiology : PACE|March 20, 2015
Clinical Significance of Nonsustained Ventricular Tachycardia on Routine Monitoring of Pacemaker PatientsNikhil Seth, Rachel Kaplan, Eduardo Bustamante, et al.
Therapeutic Advances in Gastroenterology|September 9, 2024
Artificial intelligence and machine learning technologies in ulcerative colitisChiraag Kulkarni, Derek Liu, Touran Fardeen, et al.
Journal of Crohn'S & Colitis|March 28, 2026
Statin use is associated with lower rates of stricture development in patients with Crohn's disease: a propensity score-matched study of two nationwide population databasesAbhishek Dimopoulos-Verma, Chiraag Kulkarni, C William Pike, et al.
Annals of Gastroenterology|July 23, 2025
Oral vancomycin is associated with less therapy intensification in adults with symptomatic inflammatory bowel disease and underlying primary sclerosing cholangitisChiraag Kulkarni, Sarah Talamantes, Abhishek Dimopoulos-Verma, et al.
Inflammatory Bowel Diseases|December 10, 2020
Association of Anti-TNF Therapy With Increased Risk of Acute Cholangitis in Patients With Primary Sclerosing CholangitisChiraag Kulkarni, Soumya Murag, George Cholankeril, et al.
Clinical and Translational Gastroenterology|January 21, 2025
Statin use is associated with protection against acute cholangitis in patients with primary sclerosing cholangitis: a multi-center retrospective cohort studyChiraag Kulkarni, George Cholankeril, Touran Fardeen, et al.
Clinical and Translational Gastroenterology|April 24, 2025
Statin Use Is Associated With Protection Against Acute Cholangitis in Patients With Primary Sclerosing Cholangitis: A Multicenter Retrospective Cohort StudyChiraag Kulkarni, George Cholankeril, Touran Fardeen, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical and Translational Gastroenterology|March 23, 2026
Response to Cardinale et alSidhartha R Sinha, Chiraag Kulkarni
Digestive Diseases and Sciences|May 25, 2023
Severe Diarrhea and Weight Loss Due to Protein-Losing Enteropathy: Don't Pass Up the PAS StainAaron Yeoh, Chiraag Kulkarni, Emily Ryan, et al.
Pacing and Clinical Electrophysiology : PACE|January 29, 2015
Risk prediction for adverse events during initiation of sotalol and dofetilide for the treatment of atrial fibrillationKartik Agusala, Adam Oesterle, Chiraag Kulkarni, et al.
Pacing and Clinical Electrophysiology : PACE|March 20, 2015
Clinical Significance of Nonsustained Ventricular Tachycardia on Routine Monitoring of Pacemaker PatientsNikhil Seth, Rachel Kaplan, Eduardo Bustamante, et al.
Therapeutic Advances in Gastroenterology|September 9, 2024
Artificial intelligence and machine learning technologies in ulcerative colitisChiraag Kulkarni, Derek Liu, Touran Fardeen, et al.
Journal of Crohn'S & Colitis|March 28, 2026
Statin use is associated with lower rates of stricture development in patients with Crohn's disease: a propensity score-matched study of two nationwide population databasesAbhishek Dimopoulos-Verma, Chiraag Kulkarni, C William Pike, et al.
Annals of Gastroenterology|July 23, 2025
Oral vancomycin is associated with less therapy intensification in adults with symptomatic inflammatory bowel disease and underlying primary sclerosing cholangitisChiraag Kulkarni, Sarah Talamantes, Abhishek Dimopoulos-Verma, et al.
Inflammatory Bowel Diseases|December 10, 2020
Association of Anti-TNF Therapy With Increased Risk of Acute Cholangitis in Patients With Primary Sclerosing CholangitisChiraag Kulkarni, Soumya Murag, George Cholankeril, et al.
Clinical and Translational Gastroenterology|January 21, 2025
Statin use is associated with protection against acute cholangitis in patients with primary sclerosing cholangitis: a multi-center retrospective cohort studyChiraag Kulkarni, George Cholankeril, Touran Fardeen, et al.
Clinical and Translational Gastroenterology|April 24, 2025
Statin Use Is Associated With Protection Against Acute Cholangitis in Patients With Primary Sclerosing Cholangitis: A Multicenter Retrospective Cohort StudyChiraag Kulkarni, George Cholankeril, Touran Fardeen, et al.
Pageof 1